Stock Offerings
Secondary · ATM · Shelf · PIPE Guide↗
1,208 results
1208
Total Filings
$7039.3B
Total Raised
101
424B4 Offerings
318
ATM Programs
257
PIPEs
| Date ▼ | Ticker | Sector | Industry | Mkt Cap | Type | Offer Price | Price | vs Offer | Shares | Proceeds | Underwriters | Summary |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7 | RDHL | Healthcare | Drug Manufacturers - Specialty & Generic | $2M | ATM | — | $0.48 | — | — | — | — | RedHill Biopharma Ltd. is offering up to $1,587,708 of American Depositary Shares (each representing 10,000 ordinary shares) through an at-the-market offering with H.C. Wainwright & Co., LLC, with proceeds for general corporate purposes. |
| May 7 | AVTX | Healthcare | Biotechnology | $819M | Public Offering |
$16.26
floor
|
$15.58 | -4.2% | 19.7M | $321M | Cowen, BofA, Piper Sandler | Aviatta Therapeutics selling 19.73M shares of common stock and pre-funded warrants for up to 1.4M shares at $16.26 per share; proceeds for general corporate purposes. |
| May 7 | MGEE | Utilities | Diversified Utilities | $2.6B | ATM | — | $69.24 | — | 990K | $990,099 | Morgan Stanley, Bank of America, JPMorgan, BofA, J.P. Morgan | MGE Energy offers 990,099 shares directly and enters forward sale agreements for 2,310,232 shares; proceeds fund operations with settlement expected within 20 months. |
| May 7 | IFRX | Healthcare | Biotechnology | $272M | Public Offering |
$1.97
floor
|
$1.85 | -6.1% | — | — | Oppenheimer, Raymond James, Needham | InflaRx N.V. is selling 75 million ordinary shares at $2.00 per share, raising $150 million gross ($141 million net), with proceeds to fund operations and working capital. |
| May 6 | CSV | Consumer Cyclical | Personal Products & Services | $492M | ATM |
$47.48
floor
|
$30.98 | -34.8% | — | — | Oppenheimer, Raymond James | Carriage Services, Inc. is selling up to $100 million of common stock at-the-market through Oppenheimer and Raymond James, with proceeds for general corporate purposes. |
| May 6 | FBLG | Healthcare | Biotechnology | $3M | ATM | — | $1.31 | — | — | — | — | FibroBiologics is selling up to $7,500,000 of common stock at-the-market through H.C. Wainwright & Co., with proceeds for general corporate purposes. |
| May 6 | HYPD | Healthcare | Medical - Devices | $60M | Public Offering |
$4.50
floor
|
$3.99 | -11.3% | 2.8M | $13M | — | HYPD is selling 2,777,778 common shares at $3.60/share, raising $10 million gross proceeds; use of proceeds not specified in excerpt. |
| May 6 | MGEE | Utilities | Diversified Utilities | $2.6B | ATM | — | $69.24 | — | — | — | Morgan Stanley, BofA, J.P. Morgan | MGE Energy, Inc. is raising $250 million through a $75 million direct common stock offering and $175 million in forward sale agreements with Morgan Stanley, BofA Securities, and J.P. Morgan Securities. |
| May 6 | HPK | Energy | Oil & Gas Exploration & Production | $984M | ATM |
$6.79
floor
|
$7.79 | +14.7% | — | — | — | HighPeak Energy is conducting an at-the-market offering of up to $150 million in common stock through Roth Capital Partners, with proceeds for general corporate purposes at prevailing market prices. |
| May 6 | CLRB | Healthcare | Biotechnology | $15M | Public Offering |
$2.65
floor
|
$1.82 | -31.3% | 1.6M | $4M | — | Clearbridge Investments offering 1,618,053 shares at $2.65/share ($4.3M) to raise capital; concurrent private placement includes prefunded warrants and common warrants exercisable at $2.65. |
| May 6 | IFRX | Healthcare | Biotechnology | $272M | Public Offering |
$1.97
floor
|
$1.85 | -6.1% | — | — | Oppenheimer | I can see this is a prospectus supplement for InflaRx N.V. (IFRX), but the specific offering details—share count, total offering amount, offering price per share, and use of proceeds—are not filled in the document excerpt provided. The pricing table shows placeholder values only ($___). Without these completed figures, I cannot write the requested one- |
| May 6 | RDW | Industrials | Aerospace & Defense | $2.6B | ATM |
$8.69
floor
|
$10.73 | +23.5% | — | — | Truist, J.P. Morgan, BofA, B. Riley | Redwire Corporation will raise up to $350 million selling common stock through an at-the-market offering via multiple agents; proceeds are unspecified in this excerpt. |
| May 6 | BZAIW | — | — | — | Public Offering | — | — | — | 18.9M | — | — | Blaize Holdings, Inc. is selling 18,918,918 shares of common stock at $1.85 per share, raising approximately $35 million gross proceeds for general corporate purposes. |
| May 6 | TPET | Energy | Oil & Gas Exploration & Production | $8M | ATM | — | $1.69 | — | — | — | — | Trio Petroleum Corp is selling up to $65 million of common stock through an ATM agreement with Ladenburg Thalmann to raise capital for general corporate purposes. |
| May 6 | PMI | Healthcare | Surgical & Medical Instruments & Apparatus | $9M | Public Offering |
$0.35
floor
|
$4.45 | +1171.4% | 16.7M | $6M | — | Picard Medical is raising approximately $5 million by selling 16.7 million common shares and warrant packages at $0.30 per unit, with proceeds for general corporate purposes and working capital. |
| May 6 | RSI | Consumer Cyclical | Gambling, Resorts & Casinos | $4.9B | Public Offering | — | $19.66 | — | — | — | Wells Fargo, Morgan Stanley, Jefferies, Needham, Oppenheimer | Selling holders are offering 10 million Rush Street Interactive Class A shares at $26 per share for $260 million in gross proceeds; RSI will not receive proceeds but will repurchase 1.15 million shares. |
| May 5 | CYTK | Healthcare | Biotechnology | $8.2B | Public Offering |
$66.05
floor
|
$65.64 | -0.6% | — | — | Jefferies | Cytokinetics is selling $650 million in common stock at an undisclosed price per share; underwriters have a 30-day option to purchase an additional $97.5 million; proceeds and use not specified. |
| May 5 | CLNN | Healthcare | Biotechnology | $52M | Public Offering |
$7.00
floor
|
$4.10 | -41.4% | — | — | — | Clene Inc. is selling 1,000,000 shares of common stock at $7.00 per share, raising $7,000,000 gross proceeds ($6,545,000 net after underwriting fees). |
| May 5 | CLNN | Healthcare | Biotechnology | $52M | Public Offering | — | $4.10 | — | — | — | — | Clene Inc. is offering shares of common stock at an undisclosed price per share to raise an unspecified amount; specific pricing and use of proceeds details are incomplete in this preliminary prospectus supplement. |
| May 5 | AVTX | Healthcare | Biotechnology | $819M | Public Offering |
$13.78
floor
|
$15.58 | +13.1% | — | — | Cowen, BofA | Aveo Pharmaceuticals is offering common stock and pre-funded warrants at $13.78 per share (May 4, 2026 price) to raise capital, with proceeds for general corporate purposes. |
Data sourced from SEC EDGAR 424B4, 424B5, and 8-K filings. IPOs hidden by default.
Learn more →